WANY
IART icon

Wealthspire Advisors (New York)’s Integra LifeSciences IART Stock Holding History

Wealthspire Advisors (New York)’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-294
Closed -$4.21K – 1880
2025
Q3 		$4.21K Buy
+294
New +$4.03K ﹤0.01% 2391

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wealthspire Advisors (New York)'s IART Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 294 shares — an estimated $4.21K sold.

Wealthspire Advisors (New York) first reported a position in IART in Q3 2025 and held it in 1 quarter. The position peaked at $4.21K in Q3 2025. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 294 Integra LifeSciences shares in Q4 2025, an estimated $4.21K.
  • Wealthspire Advisors (New York) first reported a position in Integra LifeSciences in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Integra LifeSciences position peaked at $4.21K in Q3 2025.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.